Delivery Order SPE2DB20D3103-SPE2DB23FP2P2

Award Date 8/4/23
Potential Completion Date 8/7/23
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Estradiol 0.01% cream. The contract has a firm fixed price of $1,552.80 and a period of performance through April 29, 2025. The award is not associated with a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to the DLA,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,478.05, is for the supply of Estradiol 0.01% Cream, a medication used in the treatment of certain medical conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award to Amerisourcebergen Drug Corp from the Defense Logistics Agency (DLA) is for the delivery of Estradiol 0.01% Cream, 42.5 grams, valued at $1,169.99. The award is a delivery order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is a $999,999,999 contract running through November 2026. This IDC serves as a primary vehicle for the company to provide a broad range of pharmaceutical products and...
This federal contract award, valued at $1,887.24, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Estradiol 0.01% cream, a prescription medication, with a completion date of June 4, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Estradiol 0.01% cream. The contract has a firm fixed price of $1,048.62 and an ultimate completion date of June 18, 2024. It is not designated as a set-aside contract. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Estradiol 0.01% cream in a 42.5 gram size. The firm-fixed-price contract has a ceiling value of $2,978.04 and is set to expire on September 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this order as a part of its larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award is for the delivery of Estradiol 0.01% Cream (42.5 grams) to the Defense Logistics Agency (DLA). The award was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company that serves as a key supplier to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract, valued at $3,927.64, is a Firm Fixed Price Delivery Order that has an ultimate...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) for the supply of Estradiol 0.01% cream. The contract has a ceiling value of $1,708.33 and a period of performance through April 3, 2023. Amerisourcebergen, a major pharmaceutical distributor, has a significant IDC with DLA Troop Support Medical valued at $999,999,999 through November 2026 to provide a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corporation (Amerisourcebergen) for the delivery of Estradiol 0.01% Cream in 42.5 gram quantities. The contract has a firm fixed price of $1,515.48 and an ultimate completion date of August 12, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and DLA Troop Support Medical for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp Corporate Office Division. The contract, valued at $1,958.33, is for the delivery of Estradiol 0.01% Cream, a pharmaceutical product, to support the medical supply chain needs of the U.S. government. The contract is a Firm Fixed Price Delivery Order with a completion date of July 24, 2024. Amerisourcebergen, a major pharmaceutical distributor,...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP2P2
    Delivery Order

This contract award to AmerisourceBergen Drug Corp is for the delivery of Estradiol 0.01% cream, a pharmaceutical product, to support federal government healthcare programs. The $2,561.18 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 7, 2023.

The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities across multiple therapeutic areas. AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs.

This specific award was not designated with a set-aside requirement, indicating open competition. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.

Generated 2/27/25, 11:03 AM